<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: cobalt</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cobalt'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22cobalt%22&t=%22cobalt%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 03:36:01 +0100</lastBuildDate>
        <item>
            <title>J&amp;J Upsets Lawyers Filing Hip Replacement Lawsuits</title>
            <link>http://www.medworm.com/index.php?rid=4478160&amp;cid=t_451335_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FSiT0rB2umeU%2F</link>
            <description>When it comes to massive product-liability litigation, drug and device makers generally make payouts after losing a trial and any appeals. After all, why incur expenses when the outcome of an unfolding number of lawsuits is far from clear? However, Johnson &amp;#038; Johnson&amp;#8217;s DePuy unit is taking what some lawyers say is a unique approach to defending the roughly 36,000 lawsuits filed over its hip replacement device, and upsetting some lawyers in the process.
The device, known as the ASR Hip System, was recalled last August after researchers found a second operation, or revision surgery, was needed after five years at rates higher than expected. That&amp;#8217;s because the so-called &amp;#8216;metal-on-metal&amp;#8217; devices contained design defects that generated cobalt and chromium particles c...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4478160</comments>
            <pubDate>Mon, 14 Feb 2011 14:16:34 +0100</pubDate>
            <guid isPermaLink="false">4478160</guid>        </item>
        <item>
            <title>20 Cancer-Causing Substances</title>
            <link>http://www.medworm.com/index.php?rid=3761398&amp;cid=t_451335_87_f&amp;fid=36050&amp;url=http%3A%2F%2Fblisstree.com%2Flive%2F20-cancer-causing-substances%2F</link>
            <description>photo: Thinkstock
A new report by the National Institute for Occupational Safety and Health, the National Institute of Environmental Health Sciences, and the National Cancer Institute lists 20 cancer-causers or potential cancer-causers. The list includes formaldehyde, which, if you remember, is one of the substances that aspartame breaks down into. It also includes titanium dioxide, which is still used in paint and sunscreen; propylene oxide, which is found in polyurethane plastics; and diesel exhaust. Even shift work is on the list — remember when we told you about how abnormal work schedules hurt your health? Check out the full list below:

Lead and lead compounds


Indium phosphide


Cobalt with tungsten carbide


Titanium dioxide


Welding fumes


Refractory ceramic fibers


Diesel e...</description>
            <author>Breastfeeding 1-2-3</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3761398</comments>
            <pubDate>Fri, 16 Jul 2010 20:02:57 +0100</pubDate>
            <guid isPermaLink="false">3761398</guid>        </item>
        <item>
            <title>American Cancer Society Releases List of 19 Chemicals To Be Avoided</title>
            <link>http://www.medworm.com/index.php?rid=3757801&amp;cid=t_451335_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F07%2Famerican-cancer-society-releases-list-19-chemicals-avoided%2F</link>
            <description>The American Cancer Society has named a list of 19 chemicals and shift work as things that may very likely signficantly increase the risk of cancer. Chemicals on the list included chloroform, formaldehyde, carbon black, titanium dioxide, indium phosphide, and cobalt tungsten carbide. (Source: Inside Surgery)</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3757801</comments>
            <pubDate>Fri, 16 Jul 2010 06:05:18 +0100</pubDate>
            <guid isPermaLink="false">3757801</guid>        </item>
        <item>
            <title>AstraZeneca Wins A Crucial Crestor Patent Trial</title>
            <link>http://www.medworm.com/index.php?rid=3710790&amp;cid=t_451335_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F-b8gjxRZsWE%2F</link>
            <description>A federal judge has struck down litigation brought by several generic drugmakers, which sought to prove that AstraZeneca&amp;#8217;s key patent on its Crestrol cholesterol pill was invalid. The outcome had been expected, but nonetheless, removed a potentially huge problem for the drugmaker, which racked up $4.5 billion in global Crestor sales last year.
In reaching his decision, US District Court Judge Joseph Farnan ruled that the generic drugmakers, a group that included Apotex, Aurobindo Pharma, Cobalt Laboratories, Mylan Laboratories, Par Pharmaceuticals, Sandoz, Sun Pharmaceuticals and Teva Pharmaceuticals, failed to prove the AstraZeneca patent was invalid because it was an obvious invention. He also decided Apotex may be held liable for infringing the patent (read the ruling).
In an inve...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3710790</comments>
            <pubDate>Tue, 29 Jun 2010 21:31:33 +0100</pubDate>
            <guid isPermaLink="false">3710790</guid>        </item>
    </channel>
</rss>

